Laurence J. Marton - 25 Aug 2021 Form 3 Insider Report for RenovoRx, Inc. (RNXT)

Role
Director
Signature
/s/ Laurence J. Marton
Issuer symbol
RNXT
Transactions as of
25 Aug 2021
Net transactions value
$0
Form type
3
Filing time
25 Aug 2021, 17:28:57 UTC
Next filing
05 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RNXT Stock Option (right to buy) 25 Aug 2021 Common Stock 32,000 $0.6500 Direct F1
holding RNXT Stock Option (right to buy) 25 Aug 2021 Common Stock 20,480 $0.1500 Direct F2
holding RNXT Stock Option (right to buy) 25 Aug 2021 Common Stock 25,438 $0.1000 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to the option began vesting monthly on January 1, 2018, and the remaining unvested shares will continue to vest according to the same schedule until fully vested on January 1, 2022.
F2 The shares subject to the option are fully vested.
F3 The shares subject to the option are fully vested.